Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DFE Pharma is a global leader in the development, production, and supply of high-quality functional excipients for the pharmaceutical and nutraceutical industries. Its products play essential roles as fillers, binders, disintegrants, carriers and stabilizers in oral solid dose forms, inhalation therapies, ophthalmic solutions and parenteral formulations. The company serves over 5,000 customers in more than 100 countries with around 450 employees worldwide. It operates five production sites across Germany, Netherlands, India and New Zealand. DFE Pharma’s excipients have been used in numerous medicinal products including COVID‑19 vaccines and treatments. The company also offers technical expertise to support formulation development through its Center of Excellence "Closer to Formulator" (C2F) facility.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DFE Pharma.